Signifier Medical Technologies Raises $35M In Series D Funding Round To Accelerate Commercialization Of Exciteosa Therapy
Signifier Medical Technologies Raises $35M In Series D Funding Round To Accelerate Commercialization Of Exciteosa Therapy
07/27/21, 4:38 PM
Location
bostonMoney raised
$35 million
Round Type
series d
Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This financing will underpin the commercialization of Signifier’s FDA-approved De Novo device and therapy, eXciteOSA®, to treat millions of patients around the world suffering from primary snoring and mild obstructive sleep apnea (OSA).
Company Info
Location
boston, massachusetts, united states
Additional Info
Signifier Medical Technologies is a pioneer in understanding and addressing the root causes of sleep disordered breathing. We are focused on the development and commercialization of innovative and non-invasive solutions for patients with conditions such as OSA and primary snoring. Founded in 2015, Signifier Medical Technologies is at the forefront of sleep therapy, focused on developing therapies that put patient experience and comfort first. Signifier has offices in London (UK), Needham (Massachusetts, USA) and Berlin (Germany).